Federal Cannabis Legalization Could Generate $8.5 Billion in Tax Revenue

December 18, 2023 · Ganjapreneur

The Tax Foundation, a D.C.-based think tank, has proposed a state and federal marijuana tax model in a recent report, suggesting that nationwide legalization could generate $8.5 billion in annual cannabis tax revenue. First reported on by Marijuana Moment, the foundation’s model aims to keep costs low to counter illicit sales and suggests higher rates for more potent products. The current state-by-state approach, mostly taxing by sales price, is described as chaotic, and the foundation emphasizes the importance of a well-designed excise tax for minimal societal impact.

Three key lessons from state marijuana taxation experiences are outlined:

  1. Cannabis tax rates should be low enough to compete with the illicit market.
  2. The potential for significant revenue from legal marijuana markets exists, but it may be volatile and take time to materialize.
  3. Consistency across jurisdictions is crucial, especially with the prospect of interstate commerce.

The report highlights that legal states earned nearly $3 billion in marijuana tax revenue last year, a figure projected to nearly triple with nationwide legalization. It discusses the challenges of taxing cannabis compared to alcohol and tobacco, due to the lack of standardized products and difficulty in measuring THC content. The foundation recommends taxing marijuana by potency or weight, as these methods better capture externalities and are simpler to apply to new product categories.

While cannabis remains federally illegal, the U.S. Census Bureau is tracking state-level cannabis tax trends. Numerous proposals and bills to legalize cannabis federally have been discussed in the US House of Representatives and Senate, but none currently have enough support to succeed.

However, in August the US Department of Health and Human Services recommended that cannabis be moved from Schedule I to Schedule III under the Controlled Substances Act, and the DEA is now conducting its own review in order to determine what action to take. While this would not directly create a federal framework for taxation (cannabis would still be considered federally illegal at Schedule III), it could help expedite congressional action. (Full Story)

In categories:Legalization Taxes
Next Post

Former U.S. Attorneys Fighting Cannabis Rescheduling

Citing the old classics reminiscent of  Reefer Madness, nearly 30 former U.S. Attorneys sent a letter to Attorney General Merrick Garland asking that cannabis not be reclassified as a Schedule III drug. While arguing that for 50 years Republican and Democratic administrations…
Read
Previous Post

Arkansas Medical Cannabis Sales Tax Funds School Lunches for Kids

The Arkansas Medical Marijuana Commission (AMMC) recently announced the benefits that the state’s medical cannabis program, with millions of dollars in cannabis tax funds helping to provide lunches for kids at school. While the state has collected $115 million from…
Read
Random Post

How to Handle Edibles In Front of the Family on Thanksgiving

It’s that time of the year when everyone is coming together to celebrate everything they are grateful for with the people they love and a lot of food. Whether you’re going to be chilling at home with your loved ones,…
Read
Random Post

Are Delayed Tax Payments a Viable Capital Allocation Strategy?

Notorious Mafia kingpin Al Capone never filed a federal income tax return, claiming he had no taxable income. Before he was convicted of tax evasion in 1931, he boasted, “They can’t collect legal taxes from illegal money.” The rationale might…
Read
Random Post

GOP Lawmakers Outraged About Marijuana And Cocaine Found At Biden White House, With One Saying It Endangers President’s ‘Well-Being’

Conservative media, as well as certain Republican lawmakers, have a new White House drug fixation after it was disclosed by the U.S. Secret Service (USSS) that agents discovered small amounts of marijuana in the West Wing twice last year, in…
Read
Random Post

Cresco and Columbia Care call off $2 billion cannabis megamerger; Sean ‘Diddy’ Combs deal also scratched

Chicago-based Cresco Labs and Columbia Care called off their $2 billion cannabis megamerger Monday, citing “evolving” market conditions that include falling stock prices, tightening credit and flattening industry sales. The companies also scratched the $185 million sale of cannabis facilities…
Read